Literature DB >> 7578719

A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia.

F A Manian1.   

Abstract

A total of 1,622 daily measurements of the level of C-reactive protein (CRP) in the serum of 40 hospitalized patients with neutropenia were made during 55 study periods from October 1990 through February 1993 (mean, 29.5 measurements per period). Clinical events were categorized into four groups: group I (bloodstream infection), group II (significant bacterial or fungal infection without bloodstream infection), group III (fever without an obvious source), and group IV (drug-related fever). There was a strong association between baseline elevation of the CRP level (> or = 100 mg/L) and tumor-associated fever (P = .0005); the resolution of such fever coincided with a decrease in the CRP level following chemotherapy. Levels of CRP increased by > or = 40 mg/L in 10 (31%) of 32 cases during the 48-72 hours preceding the clinical diagnosis of a subsequently demonstrable infection--often pneumonia without bloodstream infection. CRP values on day 2 (1 day after the diagnosis of a clinical event) were significantly higher for events in groups I and II than for those in group III (P < .01) but not those in group IV. With regard to significant infections, a day-2 CRP value of > or = 40 mg/L was 100% sensitive and an increase in CRP level of > or = 50 mg/L from day 1 to day 2 had a positive predictive value of 95%. We conclude that serial measurements of serum CRP levels may be helpful in determining the extent of evaluation required for a newly febrile neutropenic patient and possibly in accelerating the detection of an otherwise unsuspected infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578719     DOI: 10.1093/clinids/21.1.114

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients.

Authors:  H Dahl; J Marcoccia; A Linde
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

Review 2.  Treatment of fever after stroke: conflicting evidence.

Authors:  Sylwia E Wrotek; Wieslaw E Kozak; David C Hess; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2011-11       Impact factor: 4.705

3.  The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation.

Authors:  E Rintala; K Remes; T T Salmi; P Koskinen; J Nikoskelainen
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

4.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

5.  Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.

Authors:  Mizuki Aimoto; Hideo Koh; Takako Katayama; Hiroshi Okamura; Takuro Yoshimura; Shiro Koh; Satoru Nanno; Mitsutaka Nishimoto; Asao Hirose; Mika Nakamae; Takahiko Nakane; Hirohisa Nakamae; Hiroshi Kakeya; Masayuki Hino
Journal:  Infection       Date:  2014-07-20       Impact factor: 3.553

6.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

7.  Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies.

Authors:  Massimo Offidani; Laura Corvatta; Lara Malerba; Maria-Novella Piersantelli; Esther Manso; Pietro Leoni
Journal:  Support Care Cancer       Date:  2006-02-15       Impact factor: 3.603

8.  Inflammation is associated with voriconazole trough concentrations.

Authors:  Marjolijn J P van Wanrooy; Lambert F R Span; Michael G G Rodgers; Edwin R van den Heuvel; Donald R A Uges; Tjip S van der Werf; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

9.  Characteristics of febrile patients with normal white blood cell counts and high C-reactive protein levels in an emergency department.

Authors:  Kuan-Ting Liu; Tzeng-Jih Lin; Hon-Man Chan
Journal:  Kaohsiung J Med Sci       Date:  2008-05       Impact factor: 2.744

10.  Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.

Authors:  Carina Intke; Sini Korpelainen; Marika Lappalainen; Matti Vänskä; Sari Hämäläinen; Kari Pulkki; Esa Jantunen; Auni Juutilainen; Anna-Kaisa Purhonen
Journal:  Clin Exp Med       Date:  2021-07-13       Impact factor: 3.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.